{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:27:40Z","timestamp":1773296860454,"version":"3.50.1"},"reference-count":16,"publisher":"Hindawi Limited","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2518,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1742-1241.2006.00999.x","type":"journal-article","created":{"date-parts":[[2006,6,7]],"date-time":"2006-06-07T05:36:31Z","timestamp":1149658591000},"page":"863-866","source":"Crossref","is-referenced-by-count":23,"title":["Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial"],"prefix":"10.1155","volume":"60","author":[{"given":"V. L.","family":"SEREBRUANY","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. G.","family":"MIDEI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"MEILMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. I.","family":"MALININ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. R.","family":"LOWRY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2008,10,9]]},"reference":[{"key":"10.1111\/j.1742-1241.2006.00999.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists Collaboration","year":"2002","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2006.00999.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2006.00999.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1161\/01.CIR.0000091201.39590.CB","article-title":"Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study","volume":"108","author":"Peters","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2006.00999.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2006.00999.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1161\/01.CIR.0000160869.75810.98","article-title":"Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention","volume":"111","author":"Hochholzer","year":"2005","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2006.00999.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jacc.2004.09.067","article-title":"Variability in platelet responsiveness to clopidogrel among 544 individuals","volume":"45","author":"Serebruany","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2006.00999.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1161\/CIRCULATIONAHA.104.502815","article-title":"Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial","volume":"111","author":"Wiviott","year":"2005","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2006.00999.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ahj.2005.02.039","article-title":"Noncompliance in Clinical Trials","volume":"150","author":"Serebruany","year":"2005","journal-title":"Am Heart J"},{"key":"10.1111\/j.1742-1241.2006.00999.x-BIB9|cit9","volume-title":"Prescription Medicine Compliance: A Review of the Baseline of Knowledge, August 1995. Medication Regimens: Causes of Noncompliance","author":"National Council on Patient Information and Education","year":"1990"},{"key":"10.1111\/j.1742-1241.2006.00999.x-BIB10|cit10","article-title":"Platelet inhibition with prasugrel (CS-747) versus clopidogrel in patients undergoing coronary stenting: the subset from the JUMBO Trial","author":"Serebruany","journal-title":"Postgrad Med J"},{"key":"10.1111\/j.1742-1241.2006.00999.x-BIB11|cit11","article-title":"Paradoxical Rebound Platelet Activation After NSAIDS or COX-2 Inhibitors (NSADS\/COXI) Withdrawal: Which Patients are at Higher Risk for Vascular Events","author":"Serebruany","journal-title":"Am J Med"},{"key":"10.1111\/j.1742-1241.2006.00999.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/jama.286.8.954","article-title":"Risk of cardiovascular events associated with selective COX-2 inhibitors","volume":"286","author":"Mukherjee","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2006.00999.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000073976","article-title":"Attrition and non-compliance in secondary stroke prevention trials","volume":"23","author":"Gencheva","year":"2004","journal-title":"Neuroepidemiology"},{"key":"10.1111\/j.1742-1241.2006.00999.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/01.CIR.103.2.201","article-title":"Increased mortality with oral platelet glycoprotein IIb\/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials","volume":"103","author":"Chew","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2006.00999.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-8703(03)00186-8","article-title":"Roxifiban Oral Compound Kinetics Evaluation Trial-I Platelet Substudy, Effects of roxifiban on platelet aggregation and major receptor expression in patients with coronary artery disease for the Roxifiban Oral Compound Kinetics Evaluation Trial-I (ROCKET-I Platelet Substudy)","volume":"146","author":"Serebruany","year":"2003","journal-title":"Am Heart J"},{"key":"10.1111\/j.1742-1241.2006.00999.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0002-8703(98)70212-1","article-title":"Heterogeneity of platelet aggregation and major surface receptor expression in patients with acute myocardial infarction","volume":"136","author":"Serebruany","year":"1998","journal-title":"Am Heart J"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2006.00999.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2006.00999.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:06:43Z","timestamp":1643350003000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2006.00999.x"}},"subtitle":["ANTIPLATELET THERAPY"],"short-title":[],"issued":{"date-parts":[[2008,10,9]]},"references-count":16,"journal-issue":{"issue":"7"},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2006.00999.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10,9]]}}}